Sci Pharm www.scipharm.at Research article Open Access Randomized, Crossover and Single-Dose Bioquivalence Study of Two Oral Desogestrel Formulations (Film-Coated Tablets of 75 µg) in Healthy Female Volunteers | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Biowaiver monographs for immediate release solid oral dosage forms: Diclofenac sodium and diclofenac potassium A project of the International Pharmaceutical Federation FIP, Groupe BCS, www.fip.org/bcs . This article reflects the scientific opinion of the authors and not the policies of regulating agencies, the International Pharmaceutical Federation (FIP) and the World Health Organization (WHO).

Chuasuwan, B.
Binjesoh, V.
Polli, James E.
Zhang, H.
Amidon, Gordon L.
Junginger, H. E.
Midha, Kamal K.
Shah, V. P.
Stavchansky, S.
Dressman, Jennifer B.
Barends, D. M.

April 2009

Literature data are reviewed regarding the scientific advisability of allowing a waiver of in vivo ...

Randomized, Crossover and Single-Dose Bioquivalence Study of Two Oral Desogestrel Formulations (Film-Coated Tablets of 75 μg) in Healthy Female Volunteers

María PENA

March 2012

Despite the increase in the substitution of branded medicinal product with generic drugs, this is a ...

Drug safety evaluation of desogestrel

Scala, Carolina
LEONE ROBERTI MAGGIORE, Umberto
Remorgida, Valentino
Venturini, PIER LUIGI
Ferrero, Simone

January 2013

Introduction: Desogestrel (DSG) is a third-generation progestin. It is commonly used in various form...

BIOEQUIVALENCE STUDY OF ANTIMIGRAINE DRUG IN HEALTHY ADULT HUMAN SUBJECTS UNDER FED CONDITIONS

Hemant Kumar
Avijit Majumder
Akanksha Sharma

August 2016

Bioequivalence studies are the preliminary requirement for generic products to enter in the market. ...

Biowaiver monographs for immediate release solid oral dosage forms: Diclofenac sodium and diclofenac potassium A project of the International Pharmaceutical Federation FIP, Groupe BCS, www.fip.org/bcs . This article reflects the scientific opinion of the authors and not the policies of regulating agencies, the International Pharmaceutical Federation (FIP) and the World Health Organization (WHO).

Chuasuwan, B.
Binjesoh, V.
Polli, James E.
Zhang, H.
Amidon, Gordon L.
Junginger, H. E.
Midha, Kamal K.
Shah, V. P.
Stavchansky, S.
Dressman, Jennifer B.
Barends, D. M.

April 2009

Literature data are reviewed regarding the scientific advisability of allowing a waiver of in vivo ...

Biowaiver monographs for immediate release solid oral dosage forms: Diclofenac sodium and diclofenac potassium A project of the International Pharmaceutical Federation FIP, Groupe BCS, www.fip.org/bcs . This article reflects the scientific opinion of the authors and not the policies of regulating agencies, the International Pharmaceutical Federation (FIP) and the World Health Organization (WHO).

Chuasuwan, B.
Binjesoh, V.
Polli, James E.
Zhang, H.
Amidon, Gordon L.
Junginger, H. E.
Midha, Kamal K.
Shah, V. P.
Stavchansky, S.
Dressman, Jennifer B.
Barends, D. M.

April 2009

Literature data are reviewed regarding the scientific advisability of allowing a waiver of in vivo ...